GlassScriptPhysician profile
Tanya S Geist
NPI 1174666945
$43,317.70
in general payments reported to CMS, 2019-2025
74 companies · $11K in 2025
The $11K reported for 2025 was more than what 99% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,811 · 2022: $8,966 · 2023: $12K · 2024: $8,401 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,328 · Consulting Fee: $4,610 · Honoraria: $4,075 · Travel and Lodging: $2,593 · Education: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,693.32 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,327.50 |
| Consulting Fee | $4,610.00 |
| Honoraria | $4,075.00 |
| Travel and Lodging | $2,592.50 |
| Education | $241.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argenx US, INC. | $6,986.99 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Amgen INC. | $5,608.60 | 2021-2025 | Uplizna, Tavneos, Aimovig |
| Ucb, INC. | $4,858.61 | 2021-2025 | Zilbrysq, Rystiggo, Nayzilam |
| Amylyx Pharmaceuticals, INC. | $4,318.53 | 2023-2024 | Relyvrio |
| Alexion Pharmaceuticals, INC. | $3,957.14 | 2021-2025 | Ultomiris, Soliris |
| Genentech USA, INC. | $1,950.68 | 2021-2025 | Ocrevus Zunovo, Ocrevus |
| Janssen Biotech, INC. | $1,468.52 | 2025 | |
| Abbvie INC. | $1,360.54 | 2021-2025 | |
| Mdd US Operations, LLC | $1,257.90 | 2022-2025 | Gocovri, Apokyn, Gocovri |
| Novartis Pharmaceuticals Corporation | $1,064.75 | 2021-2025 | |
| Biogen, INC. | $754.75 | 2021-2025 | Vumerity, Tysabri, Spinraza |
| Alnylam Pharmaceuticals INC. | $736.25 | 2021-2025 | Amvuttra, Onpattro |
| Teva Pharmaceuticals USA, INC. | $669.50 | 2021-2024 | Austedo Xr, Austedo |
| Horizon Therapeutics Plc | $605.58 | 2021-2023 | Uplizna |
| Tanabe Pharma America, INC. | $534.51 | 2022-2025 | Radicava |
Show all 74 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $453.26 | 2021-2025 | Mavenclad, Mavenclad |
| Nevro Corp. | $317.77 | 2021-2024 | Senza |
| Pfizer INC. | $272.87 | 2023-2025 | |
| Sk Life Science, INC. | $272.38 | 2021-2024 | |
| Avanir Pharmaceuticals, INC. | $266.06 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $263.08 | 2021-2023 | Spravato |
| Neurocrine Biosciences, INC. | $261.63 | 2021-2025 | Ingrezza, Ongentys |
| Catalyst Pharmaceuticals, INC. | $256.93 | 2022-2025 | Firdapse |
| Lundbeck LLC | $244.64 | 2021-2025 | Vyepti |
| Jazz Pharmaceuticals INC. | $230.05 | 2021-2025 | |
| Csl Behring | $217.93 | 2021-2025 | Hizentra |
| Genzyme Corporation | $216.88 | 2023-2025 | |
| Lilly USA, LLC | $216.34 | 2021-2025 | Reyvow, Emgality, Amyvid |
| Ge Healthcare | $198.27 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $196.92 | 2021-2025 | Wainua |
| Merz Pharmaceuticals, LLC | $174.48 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $168.12 | 2022 | |
| Livanova USA, INC. | $161.96 | 2021-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Genentech, INC. | $157.53 | 2021-2025 | Ocrevus, Enspryng |
| Tg Therapeutics, INC. | $154.69 | 2023-2025 | |
| Celgene Corporation | $151.25 | 2021-2025 | Zeposia |
| Grifols USA, LLC | $150.27 | 2022-2025 | Gamunex-C |
| Adamas Pharmaceuticals, INC. | $139.25 | 2021 | |
| Octapharma USA, INC. | $131.20 | 2023-2025 | Panzyga, Octagam Immune Globulin (Human) |
| Kyowa Kirin, INC. | $124.53 | 2021-2024 | Nourianz |
| Supernus Pharmaceuticals, INC. | $120.24 | 2021-2025 | Qelbree |
| Abbott Laboratories | $113.17 | 2022-2024 | Infinity |
| Acadia Pharmaceuticals INC | $111.24 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $110.99 | 2023-2025 | Hyqvia, Gammagard |
| Mallinckrodt Hospital Products INC. | $101.21 | 2021-2025 | Acthar |
| Arbor Pharmaceuticals, INC. | $90.09 | 2021-2022 | |
| Eisai INC. | $89.00 | 2021-2025 | |
| Upsher-Smith Laboratories LLC | $63.80 | 2021-2022 | |
| Acorda Therapeutics, INC | $63.36 | 2023 | Inbrija, Ampyra |
| Otsuka America Pharmaceutical, INC. | $61.88 | 2023-2024 | Nuedexta |
| Biohaven Pharmaceuticals, INC. | $61.64 | 2021 | |
| Vanda Pharmaceuticals INC. | $61.10 | 2025 | Ponvory |
| Axsome Therapeutics, INC. | $60.12 | 2023-2024 | Sunosi |
| Averitas Pharma INC. | $59.50 | 2025 | Qutenza |
| Avion Pharmaceuticals | $57.92 | 2022 | |
| Harmony Biosciences LLC | $57.57 | 2023-2024 | Wakix |
| Azurity Pharmaceuticals, INC. | $52.53 | 2024-2025 | Horizant, Zonisade |
| Amneal Pharmaceuticals LLC | $52.20 | 2022-2025 | Crexont |
| Banner Life Sciences, LLC | $42.39 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $41.44 | 2024 | Keveyis |
| Boston Scientific Corporation | $38.10 | 2023 | Watchman Access System |
| Ani Pharmaceuticals, INC. | $33.95 | 2022-2025 | Purified Cortrophin Gel |
| Neurelis, INC. | $32.36 | 2024 | Valtoco |
| Allergan, INC. | $30.84 | 2021 | |
| Corium, LLC | $24.87 | 2023 | Adlarity |
| Sarepta Therapeutics, INC. | $21.37 | 2022 | |
| Invivyd INC | $20.27 | 2025 | Pemgarda |
| Inspire Medical Systems, INC. | $19.68 | 2024 | Inspire |
| Sobi, INC | $17.89 | 2021 | |
| Impel Pharmaceuticals LLC | $16.63 | 2024 | Trudhesa |
| Cycle Pharmaceuticals INC | $16.27 | 2025 | Tascenso Odt, Bafiertam |
| Collegium Pharmaceutical, INC. | $15.77 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.34 | 2022 | |
| Idorsia Pharmaceuticals US INC | $12.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tanya Geist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.